| Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017 (NCT03003468) | Lawrence Feldman, MD | 2017-07-11 |
| Validation of ICG to Identify the Urethra During Rectal Surgery (NCT03204201) | Oxford University Hospitals NHS Trust | 2017-07-11 |
| Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects (NCT03214159) | First Affiliated Hospital of Zhejiang University | 2017-07-11 |
| Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers (NCT03213145) | Enanta Pharmaceuticals, Inc | 2017-07-11 |
| Epigenetic Reprogramming in Relapse/Refractory AML (NCT03263936) | Therapeutic Advances in Childhood Leukemia Consortium | 2017-07-11 |
| Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage (NCT03194932) | St. Jude Children's Research Hospital | 2017-07-11 |
| A Study of TAS-116 in Patients With Solid Tumors (NCT02965885) | Taiho Oncology, Inc. | 2017-07-10 |
| Oxandrolone in Healthy Adults: A Relative Bioavailability Study (NCT03218631) | University of Utah | 2017-07-10 |
| CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia (NCT03984968) | The First Affiliated Hospital of Soochow University | 2017-07-10 |
| To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC. (NCT02249650) | Taiwan Sunpan Biotechnology Development Co., Ltd. | 2017-07-10 |
| Micra Atrial Tracking Using a Ventricular Accelerometer Study (NCT03157297) | Medtronic Cardiac Rhythm and Heart Failure | 2017-07-10 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7049665 in Healthy Volunteers (NCT03221179) | Hoffmann-La Roche | 2017-07-10 |
| Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization (NCT03061097) | Microbiome Health Research Institute | 2017-07-10 |
| Absorption, Metabolism, Excretion and Absolute Bioavailability (NCT03250039) | Pfizer | 2017-07-10 |
| CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab (NCT03123783) | Apexigen America, Inc. | 2017-07-10 |
| Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy (NCT03399331) | American University of Beirut Medical Center | 2017-07-10 |
| Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy (NCT03106610) | M.D. Anderson Cancer Center | 2017-07-07 |
| Safety and Immunogenicity Study of DNA.HTI, MVA.HTI and ChAdOx1.HTI in HIV-1-positive Patients (AELIX-002) (NCT03204617) | Aelix Therapeutics | 2017-07-07 |
| The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial (NCT03158935) | University Health Network, Toronto | 2017-07-07 |
| Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers (NCT03235141) | Beijing Tongren Hospital | 2017-07-07 |
| Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke (REVISE-1) (NCT03210051) | Capital Medical University | 2017-07-07 |
| Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma (NCT03041701) | National Cancer Institute (NCI) | 2017-07-07 |
| A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection (NCT03253471) | Alios Biopharma Inc. | 2017-07-07 |
| Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer (NCT03095781) | Emory University | 2017-07-07 |
| Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects (NCT03165097) | Idorsia Pharmaceuticals Ltd. | 2017-07-07 |
| A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer (NCT03213054) | Oncolys BioPharma Inc | 2017-07-07 |
| Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male Subjects. (NCT03362008) | Jeil Pharmaceutical Co., Ltd. | 2017-07-06 |
| Study of AT-527 in Healthy and HCV-Infected Subjects (NCT03219957) | Atea Pharmaceuticals, Inc. | 2017-07-06 |
| The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers (NCT02982798) | Jeil Pharmaceutical Co., Ltd. | 2017-07-06 |
| Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) (NCT02903537) | Fundació Institut Germans Trias i Pujol | 2017-07-06 |
| TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds (NCT02737748) | Transwell Biotech Co., Ltd. | 2017-07-06 |
| Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS (NCT03066648) | Novartis Pharmaceuticals | 2017-07-06 |
| Vitamin C in Cardiac Surgery Patients (NCT03123107) | Geisinger Clinic | 2017-07-06 |
| Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors (NCT03154294) | Avera McKennan Hospital & University Health Center | 2017-07-06 |
| A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness (NCT03163511) | ViaCyte | 2017-07-06 |
| First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas (NCT03188965) | Bayer | 2017-07-06 |
| Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation (NCT02814058) | Biolab Sanus Farmaceutica | 2017-07-05 |
| Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers (NCT03184168) | Pfizer | 2017-07-05 |
| A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics (NCT03019276) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2017-07-05 |
| Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation (NCT02817750) | Biolab Sanus Farmaceutica | 2017-07-05 |
| A Safety and Tolerability Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus (NCT03162926) | ViaCyte | 2017-07-05 |
| Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects (NCT03087942) | Novartis Pharmaceuticals | 2017-07-05 |
| A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) (NCT03193190) | Hoffmann-La Roche | 2017-07-05 |
| A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants (NCT04720092) | Bayer | 2017-07-05 |
| A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men (NCT04727021) | Bayer | 2017-07-04 |
| Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers (NCT03203564) | Isofol Medical AB | 2017-07-04 |
| Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) (NCT02758587) | NHS Greater Glasgow and Clyde | 2017-07-04 |
| Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level (NCT03211403) | Atridia Pty Ltd. | 2017-07-04 |
| An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1) (NCT03198130) | Regeneron Pharmaceuticals | 2017-07-03 |
| A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR) (NCT03145909) | AbbVie | 2017-07-03 |
| A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma (NCT03126591) | Eli Lilly and Company | 2017-07-03 |
| A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2 (NCT03203421) | University of Oxford | 2017-07-03 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma (NCT02911142) | National Cancer Institute (NCI) | 2017-07-03 |
| A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer (NCT03215511) | Bayer | 2017-07-03 |
| A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms (NCT03213353) | Johnson & Johnson Consumer and Personal Products Worldwide | 2017-07-03 |
| A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 Diabetes (NCT03215498) | Novo Nordisk A/S | 2017-07-03 |
| A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults (NCT03208101) | LG Chem | 2017-07-03 |
| A Phase I Study of ICP-022 in Healthy Subjects (NCT03189017) | Innocare Pharma Australia Pty Ltd | 2017-07-03 |
| Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided Technique (NCT03442543) | Mansoura University | 2017-07-02 |
| Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001) (NCT03179436) | Merck Sharp & Dohme LLC | 2017-07-02 |
| PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure (NCT02667535) | Biolab Sanus Farmaceutica | 2017-07-01 |
| Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (NCT03043664) | Duke University | 2017-07-01 |
| CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia (NCT03275493) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2017-07-01 |
| Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas (NCT03189186) | University of California, Irvine | 2017-07-01 |
| Persisting Effects of Psilocybin (NCT02971605) | Johns Hopkins University | 2017-07-01 |
| Treatment of Chronic Migraine Headaches. (NCT03220113) | Corona Doctors Medical Clinics, Inc. | 2017-07-01 |
| A Randomized Trial to Prevent HIV Among Gay Couples (NCT03189394) | San Francisco State University | 2017-07-01 |
| Lonquek for Autologous Stem Cell Mobilization (NCT02488382) | Sheba Medical Center | 2017-07-01 |
| Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) (NCT02997956) | University of Michigan Rogel Cancer Center | 2017-07-01 |
| GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers (NCT03198052) | Second Affiliated Hospital of Guangzhou Medical University | 2017-07-01 |
| Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis (NCT03576287) | Tanja Todberg, MD | 2017-07-01 |
| Cheese Consumption and Human Microvascular Function (NCT03376555) | Lacy Alexander | 2017-07-01 |
| Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids (NCT02940509) | Milton S. Hershey Medical Center | 2017-07-01 |
| Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer (NCT03281382) | Henry Ford Health System | 2017-07-01 |
| Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF) (NCT03680378) | Allecra | 2017-07-01 |
| CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia (NCT04351022) | The First Affiliated Hospital of Soochow University | 2017-07-01 |
| Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular Block (NCT02888067) | Thomas Schricker | 2017-07-01 |
| Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients (NCT03066817) | New York City Health and Hospitals Corporation | 2017-07-01 |
| GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression (NCT03198546) | Second Affiliated Hospital of Guangzhou Medical University | 2017-07-01 |
| Oral Docetaxel in Patients With Normal or Impaired Liver Function (NCT05084456) | Modra Pharmaceuticals | 2017-07-01 |
| Pharmacokinetics Study of Eplerenone Coated Tablets (NCT02957435) | Biolab Sanus Farmaceutica | 2017-07-01 |
| Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML) (NCT04884984) | The First Affiliated Hospital of Soochow University | 2017-07-01 |
| Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition (NCT04051840) | The First Affiliated Hospital with Nanjing Medical University | 2017-07-01 |
| Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors (NCT03713905) | Guangzhou Gloria Biosciences Co., Ltd. | 2017-07-01 |
| Phase 1 Crohn's Pediatric Sub-study of MSC AFP (NCT03014219) | William A. Faubion, M.D. | 2017-07-01 |
| Evaluation of CPP-ACP Prophylactic Effect on Enamel Surface During Orthodontic Treatment (NCT03187548) | Cairo University | 2017-07-01 |
| Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1% (NCT02667561) | Biolab Sanus Farmaceutica | 2017-07-01 |
| OTR Tablet 40 mg Fasted-state Bioequivalence Study (NCT03398278) | Mundipharma (China) Pharmaceutical Co. Ltd | 2017-06-30 |
| Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome (NCT03226444) | TearSolutions, Inc. | 2017-06-30 |
| Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers (NCT03175211) | Boehringer Ingelheim | 2017-06-30 |
| Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma (NCT03174197) | M.D. Anderson Cancer Center | 2017-06-30 |
| Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant (NCT03212313) | Biotie Therapies Inc. | 2017-06-30 |
| Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma (NCT03168061) | NanoCarrier Co., Ltd. | 2017-06-30 |
| ACTolog in Patients With Solid Cancers (NCT02876510) | Immatics US, Inc. | 2017-06-30 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers (NCT03411122) | Sumitomo Pharma America, Inc. | 2017-06-30 |
| AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas (NCT03205176) | AstraZeneca | 2017-06-30 |
| A Study of Two Different Formulations of LY3074828 in Healthy Participants (NCT03188510) | Eli Lilly and Company | 2017-06-30 |
| A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies (NCT03191773) | Second Affiliated Hospital of Guangzhou Medical University | 2017-06-30 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus (NCT02920424) | Janssen Research & Development, LLC | 2017-06-30 |
| Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib (NCT03822520) | Samsung Medical Center | 2017-06-30 |